Evidence map›Paper›PMID 32743401›Full record

ArticleIJU case reports2019

Multiple angiomyolipomas mimicking metastases of concurrent clear cell renal cell carcinoma.

Takahiro Narimatsu, Toshitaka Shin, Tadamasa Shibuya, Toru Inoue, Kenichi Hirai, Tadasuke Ando, Fuminori Sato, Tsutomu Daa, Hiromitsu Mimata

Open access · goldAbstract readCase Reports
In one paragraph

Article in IJU case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Takahiro NarimatsuDepartments of Urology Faculty of Medicine Oita University Oita Japan.ORCID https://orcid.org/0000-0003-4848-9178
Toshitaka ShinDepartments of Urology Faculty of Medicine Oita University Oita Japan.
Tadamasa ShibuyaDepartments of Urology Faculty of Medicine Oita University Oita Japan.
Toru InoueDepartments of Urology Faculty of Medicine Oita University Oita Japan.
Kenichi HiraiDepartments of Urology Faculty of Medicine Oita University Oita Japan.
Tadasuke AndoDepartments of Urology Faculty of Medicine Oita University Oita Japan.
Fuminori SatoDepartments of Urology Faculty of Medicine Oita University Oita Japan.
Tsutomu DaaDiagnostic Pathology Faculty of Medicine Oita University Oita Japan.
Hiromitsu MimataDepartments of Urology Faculty of Medicine Oita University Oita Japan.
Oita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionConcurrence of clear cell renal cell carcinoma and angiomyolipoma is quite rare. We report a case of large localized clear cell renal cell carcinoma with concurrent multiple angiomyolipomas mimicking lymph node metastases. CASE PRESENTATION: A 60-year-old woman presented with general malaise, weight loss, and intermittent fever. Computed tomography scan demonstrated an 8-cm mass in the left kidney, enlarged para-aortic lymph nodes, and small renal nodules adjacent to the main tumor. She was diagnosed preoperatively as having clear cell renal cell carcinoma (cT3a) with multiple para-aortic lymph node metastases, and underwent laparoscopic radical nephrectomy and dissection of the para-aortic lymph nodes. Pathologically, the main tumor was diagnosed as clear cell renal cell carcinoma. By contrast, both the para-aortic lymph nodes and nodules were diagnosed as lipid-poor angiomyolipomas.

conclusionWith the expanding first-line use of molecular targeted therapy for metastatic renal cell carcinoma, nephrectomy may be avoided by overdiagnosis. Upfront nephrectomy can avoid overdiagnosis and undertreatment of nonmetastatic renal cell carcinoma.

Indexed as

clear cell renal cell carcinomakidney cancerlipid‐poor angiomyolipomamultiple angiomyolipomas

Identifiers

PMID32743401
PMCPMC7292055
OpenAlexW2933887531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.